» Authors » Marios Spanakis

Marios Spanakis

Explore the profile of Marios Spanakis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 175
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sevim C, Ozkaraca M, Kara M, Taghizadehghalehjoughi A, Genc S, Yeni Y, et al.
Mol Med Rep . 2024 Dec; 31(2). PMID: 39704189
The present study investigated the impact of boric acid (BA) and borax (BX) on markers of inflammation and modifications in miR‑21/PTEN/AKT pathway genes in the liver and kidney tissues of...
2.
Fragkiadaki P, Apetroaei M, Kouvidi E, Vakonaki E, Renieri E, Fragkiadoulaki I, et al.
Cytogenet Genome Res . 2024 Dec; 164(5-6):202-210. PMID: 39662066
Introduction: Telomeres, repetitive DNA sequences at chromosome ends, shorten with cell division, countered by telomerase. Short telomeres are linked to cardiovascular disease (CVD), alongside its risk factors like aging, hypertension,...
3.
Boura D, Spanakis M, Markakis G, Notas G, Lionis C, Tzanakis N, et al.
Children (Basel) . 2024 Jun; 11(6). PMID: 38929296
Respiratory disorders significantly impact adolescents' health, often resulting in hospital admissions. Meteorological elements such as wind patterns have emerged as potential contributors to respiratory symptoms. However, it remains uncertain whether...
4.
Genc S, Taghizadehghalehjoughi A, Naldan M, Gulcu O, Caglayan C, Spanakis M, et al.
Exp Ther Med . 2024 Jan; 27(2):82. PMID: 38274343
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (COVID-19) represented a global public health crisis and the most significant pandemic in modern times. Transmission...
5.
Spanakis M, Fragkiadaki P, Renieri E, Vakonaki E, Fragkiadoulaki I, Alegakis A, et al.
Front Sports Act Living . 2024 Jan; 5:1327792. PMID: 38260814
In modern athlete assessment, the integration of conventional biochemical and ergophysiologic monitoring with innovative methods like telomere analysis, genotyping/phenotypic profiling, and metabolomics has the potential to offer a comprehensive understanding...
6.
Spanakis M, Alon-Ellenbogen D, Ioannou P, Spernovasilis N
Pharmacy (Basel) . 2023 Aug; 11(4). PMID: 37624085
Evidence-based prescribing requires taking into consideration the many aspects of optimal drug administration (e.g., dosage, comorbidities, co-administered drugs, etc.). A key issue is the administration of drugs for acute disorders...
7.
Cicek B, Hacimuftuoglu A, Yeni Y, Danisman B, Ozkaraca M, Mokhtare B, et al.
J Pers Med . 2023 Apr; 13(4). PMID: 37109035
(1) Background: Doxorubicin (DOX) is extensively used for cancer treatments; however, its clinical application is limited because of its cardiotoxic adverse effects. A combination of DOX and agents with cardioprotective...
8.
Spanakis M
Pharmaceutics . 2023 Mar; 15(3). PMID: 36986874
Personalized/precision medicine (PM) originates from the application of molecular pharmacology in clinical practice, representing a new era in healthcare that aims to identify and predict optimum treatment outcomes for a...
9.
Spanakis M, Ioannou P, Tzalis S, Chouzouri F, Patelarou E, Kofteridis D, et al.
Adv Respir Med . 2023 Feb; 91(1):74-92. PMID: 36825942
: Patients with respiratory disorders often have additional diseases and are usually treated with more than one medication to manage their respiratory conditions as well as additional comorbidities. Thus, they...
10.
Spanakis M, Ioannou P, Tzalis S, Papakosta V, Patelarou E, Tzanakis N, et al.
J Clin Med . 2022 Dec; 11(23). PMID: 36498745
The modulation of the pharmacological action of drugs due to drug-drug interactions (DDIs) is a critical issue in healthcare. The aim of this study was to evaluate the prevalence and...